Category: Open access
-
Updates from the field – AVENIR II in November
—
published by
AVENIR II in Niger – November 2024 November saw the successful completion of a number of activities, including the continued mass distribution of azithromycin in the Dosso and Tahoua regions. Outstanding coverage This campaign has enabled coverage areas for the intervention to be extended, particularly in the surveillance integrated health centres (CSIs), of which there…
-
REACH 2024 Annual Meeting report and thanks
The REACH Network Secretariat is pleased to share its REACH 2024 Annual Regional Meeting report, highlighting the key discussions, outcomes, and milestones of the three-day gathering – in Abuja, Nigeria, and online – between 29 and 31 October 2024. This year’s meeting culminated with the signing of the Abuja Declaration on REACH for Child Survival.…
-
The year in review:
A tribute to Professor Nigel Klein, 1960–2024While it has been a momentous year for the REACH Network, it has also been a year in which the REACH family lost a brilliant and valued member. It is our privilege to pay tribute to Professor Nigel Klein, who died earlier this year after a long illness.
-
AVENIR II in September 2024
September was a busy month for AVENIR, with activities ranging from training courses to meetings with health and district authorities. Preparations for AVENIR II in Zinder With the second phase of the project progressing successfully in the Maradi, Dosso and Tahoua regions, activities will begin in the Zinder region during the last quarter of 2024.…
-
REACH Network annual meeting leads to historic Abuja Declaration
—
published by
African leaders and global health partners commit to saving children’s lives in Africa The Co-chairs of the Resiliency through Azithromycin for Children (REACH) Network, Coordinating Minister of Health and Social Welfare of Nigeria, Muhammad Ali Pate and Professor Samba Sow, former Minister of Health of Mali, today formally signed the Abuja Declaration on REACH for…
-
REACH Niger publishes important results demonstrating efficacy of azithromycin in reducing child mortality
Writing in the prestigious New England Journal of Medicine, the AVENIR study group demonstrate that distributing azithromycin twice a year to children aged 1 to 59 months significantly reduced mortality and that including older children in treatment was more effective than targeting infants aged 1 to 11 months only.
-
Updates from the AVENIR project in Niger – August 2024
The “Azithromycine pour la Vie des Enfants au Niger” (“Azithromycin to Save the Lives of Children in Niger”) project, known as AVENIR, continues to make significant progress in reducing child mortality and morbidity in Niger. One of the highlights of the AVENIR project in August was the successful completion of data collection on pregnancy history in the Tahoua and Dosso…
-
AVENIR project updates, July 2024
A growing intervention The second phase of the AVENIR project is getting underway in the Dosso region of Niger during the fourth quarter of 2024. In preparation for this intervention, a national coordination team has been assigned to the region to prepare the ground for future activities and to ensure that all stakeholders are fully…
-
REACH Mali begins national azithromycin distribution in Ségou
On Friday, 2 August 2024, the REACH Mali team began mass drug administration (MDA) in Baroueli, in the Ségou region, some 200km east of the capital, Bamako. The REACH project to distribute azithromycin for child survival took a major step forward this week as Mali began rolling out its national scale-up of the life-saving intervention.…
-
Azithromycin for child survival in Niger – implementation and research
Under the patronage of the Minister of Public Health, Population and Social Affairs, Niger launched the second phase of the AVENIR project on Tuesday, 19 March 2024. The official ceremony was attended by international organisations, members of the national REACH network, local and international NGOs, and by national associations, representatives of all Niger’s regional health…